| Literature DB >> 21784343 |
Bruno Vellas1, Alain Pesce, Philippe H Robert, Paul S Aisen, Sonia Ancoli-Israel, Sandrine Andrieu, Jesse Cedarbaum, Bruno Dubois, Eric Siemers, Jean-Paul Spire, Michael W Weiner, Thomas S May.
Abstract
The recruitment and retention of patients are among the greatest challenges currently being faced by researchers who conduct Alzheimer's disease (AD) clinical trials. To discuss these challenges and other major issues associated with clinical research in AD, an international workshop was organized by the Association Monégasque pour la recherche sur la Maladie d'Alzheimer at Monte Carlo, Monaco, in February 2010, with the participation of leading research experts in the field of Alzheimer's. Key topics discussed were as follows: (1) the selection, recruitment, and retention of clinical trial subjects; (2) international co-operation among researchers; and (3) patient rights and informed consent for participants in clinical trials. This article highlights some of the challenges faced by investigators when conducting clinical trials in AD, and it also offers some recommendations aimed at overcoming these challenges.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21784343 DOI: 10.1016/j.jalz.2010.05.2020
Source DB: PubMed Journal: Alzheimers Dement ISSN: 1552-5260 Impact factor: 21.566